Cite
HARVARD Citation
Katz, M. et al. (n.d.). A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer. Journal for immunotherapy of cancer. p. . [Online].